Compare Repligen Corporation Common Stock (RGEN) vs Wheaton Precious Metals Corp (WPM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs Wheaton Precious Metals Corp — how do they compare? Repligen Corporation Common Stock trades at $178.2 (market cap $11.31B), while Wheaton Precious Metals Corp trades at $132.3 (market cap $58.87B). The key difference: Wheaton Precious Metals Corp is far larger — about 5.2× Repligen Corporation Common Stock's market cap, and Wheaton Precious Metals Corp pays a 0.6% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and Wheaton Precious Metals Corp for 66 Days on average.
| RGEN | WPM | |
|---|---|---|
Market Cap | $11.31B | $58.87B |
Volume | 1,216,919 | 1,966,041 |
Sector | Health | Basic Materials |
52-Week High | $194.57 | $165.72 |
52-Week Low | $102.87 | $94.37 |
Typical Hold Time | 0 Days | 66 Days |
Enterprise Value | $11.20B | $60.74B |
Dividend Yield | — | 0.6% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Wheaton Precious Metals (WPM) trades at $136.03, down 1.51% on the day, amid a bullish technical setup and strong fundamentals. The stock shows robust revenue growth, with 2025 revenue reaching $2.31 billion and net income of $1.47 billion, supported by a 64.66% net margin. Recent news highlights expansion plans targeting 1.2 million ounces by 2030, with a fully funded pipeline driving investor optimism.
The outlook remains positive given analyst consensus of a $164.80 price target and 80% buy ratings. Key risks include execution of growth targets and sensitivity to gold prices, but strong cash flow and institutional interest underpin potential upside for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About Wheaton Precious Metals Corp
Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →
